Consistent with the CMS updated 340B modifier guidance, CMS proposes in 427.303(b)(1)(ii) excluding separately payable billing units in claim lines for institutional providers with the JG and TB modifiers from identified final action claims with dates of service through December 31, 2024
We are considering whether alternatives to the active engagement approach for the measures under the Public Health and Clinical Data Exchange objective could better allow us to assess MIPS eligible clinician's performance, meet the data needs of PHAs, and ultimately allow us to incentivize increased performance in these areas
First, you insert the swab applicator or sponge in the mouth, completely saturating it
We did not simulate the addition of quality measures described in section IV.A.4.e.(1)(d)(i) since we use ( existing quality measure data from the CY 2022 performance period which does not include new measures
We recognized in the CY 2023 PFS final rule in response to those comments that there is a great deal of evidence suggesting that dental health is generally an important component of overall health
CMS intends to provide technical instructions separate from this rulemaking to manufacturers of Part D rebatable drugs regarding how to access Rebate Reports and how to receive notifications alerting the manufacturer when information is available
